Form 8-K - Current report:
SEC Accession No. 0001213900-25-040209
Filing Date
2025-05-06
Accepted
2025-05-06 16:49:29
Documents
15
Period of Report
2025-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0241060-8k_rafael.htm   iXBRL 8-K 39281
2 PURCHASE AGREEMENT, DATED AS OF MAY 6, 2025, BETWEEN THE COMPANY AND HOWARD S. J ea024106001ex99-1_rafael.htm EX-99.1 56449
  Complete submission text file 0001213900-25-040209.txt   331153

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rfl-20250506.xsd EX-101.SCH 3777
4 XBRL DEFINITION FILE rfl-20250506_def.xml EX-101.DEF 26617
5 XBRL LABEL FILE rfl-20250506_lab.xml EX-101.LAB 36669
6 XBRL PRESENTATION FILE rfl-20250506_pre.xml EX-101.PRE 25241
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0241060-8k_rafael_htm.xml XML 5666
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 25918011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)